Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? by Engelen, SE, Robinson, AJB, Zurke, Y-X, Monaco, C

Cell selectivity in succinate receptor SUCNR1/GPR91 signaling in skeletal muscle by Abdelmoez, AM, Dmytriyeva, O, Zurke, Y-X, Trauelsen, M, Marica, AA, Savikj, M, Smith, JAB, Monaco, C, Schwartz, TW, Krook, A, Pillon, NJ

Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complications by Dib, L, Koneva, LA, Edsfeldt, A, Zurke, Y-X, Sun, J, Nitulescu, M, Attar, M, Lutgens, E, Schmidt, S, Lindholm, MW, Choudhury, RP, Cassimjee, I, Lee, R, Handa, A, Goncalves, I, Sansom, SN, Monaco, C

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells by Engelen, SE, Ververs, FA, Markovska, A, Lagerholm, BC, Kraaijenhof, JM, Yousif, LI, Zurke, Y-X, Gulersonmez, CM, Kooijman, S, Goddard, M, van Eijkeren, RJ, Jervis, PJ, Besra, GS, Haitjema, S, Asselbergs, FW, Kalkhoven, E, Ploegh, HL, Boes, M, Cerundolo, V, Hovingh, GK, Salio, M, Stigter, EC, Rensen, PC, Monaco, C, Schipper, HS